• À§¾Ï°ú µ¿¹ÝµÈ ¿ø¹ß¼º ¾Ç¼º Á¾¾ç

• Multiple Primary Cancers in the Stomach and Different Organs

• Àüº´¹«

• ±è³²ÀÏ/±èÁ¤¼ö/ÀüÇظí/À¯½ÂÁø/±èÀ缺/±è¼ºÈÆ/ÀÌÀºÁ¤

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  394 ~ 404

• ¿ø°Ý ÀüÀÌµÈ ½Å¼¼Æ÷¾ÏÀÇ ÀÚ¿¬ÅðÇà 1¿¹

• A Case of Spontaneous Regression of Metanstatic Renal Cell Carcinoma

• ¼­¿µ¹®

• ÀÌÈñÀÚ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  387 ~ 393

• ¾ç¼º ¹× ¾Ç¼º Á¾¾çÀÇ ±âÀú¸· º¯È­¿¡ °üÇÑ º´¸®Á¶Á÷ÇÐÀû ¿¬±¸

• A Histopathologic Study on Basement Membrane Alteration in the Benign and Malignant Tumors

• ¼­ÀçÈ«

• ÀÌÇýÁø, À̹ÌÀÚ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  375 ~ 386

• ÀÚ¿¬»ìÇؼ¼Æ÷ Á¶ÀÛ¿¡ µû¸¥ ÀüÀ̾ÏÀÇ ÀüÀ̾ç»ó º¯È­¿Í ¼÷Áָ鿪±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Effects of Natural Killer Cell Manupuiation on the Metastatic Cancer and Host Immune Response

• ÃÖ½ÂÈÆ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  368 ~ 374

• À¯ÀüÀÚ¿ä¹ýÀ» À§ÇÑ HLA-B7 DNA/Liposome ComplexÀÇ ÀüÀӻ󿬱¸

• Preclinical Study of HLA_B7 DNA/Liposome Complex for Gene Therapy

• À±¼ºÁØ

• ±è¿ø¼®/½ÇÀ籸/ÀÌ»ó±¸/À̱âÇü/Çã´ë¼®/±è³ë°æ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  358 ~ 367

• E2/MIC2 Ç׿ø(CD99)¿¡ ´ëÇÑ Ç×ü: µ¿Á¤ ¹× Ư¼º ºÐ¼®

• An Antibody Against E2/MIC2 Antigen (CD99): Identification and Characterization

• Á¤°æõ

• ±èÅÂÁø/Á¤µÎÇö/À̰DZ¹/ÇÑÀåÈñ/¹Ú¼ºÈ¸

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  350 ~ 357

• ¿øÀڷº´¿ø¿¡ ³»¿øÇÑ ¾ÏȯÀÚÀÇ Åë°èÀû ºÐ¼®

• Statistical Analysis on Cancer Patients of Korea Cancer Center Hospital

• ÀÌÁø¿À

• ÃÖ¼ö¿ë/¹é³²¼±/½ÉÀ±»ó/·ù¼º·Ä/ÀÌÁ¾ÀÎ/ÀÌÀǵ·/Áø¼öÀÏ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  336 ~ 349

• ±ÙħÀ±¼º Grade III ¹æ±¤¾ÏÀÇ ¹æ±¤ÀüÀûÃâ¼úÀü nm23-H1°ú p53 ´Ü¹é¹ßÇöÀ» ÀÌ¿ëÇÑ ¸²ÇÁÀý ÀüÀÌÀÇ ¿¹Ãø

• Prediction of Lymph Node Metastasis Based on p53 and nm23-Hi Expression in Muscle Invasive Grade III...

• ¹Úµ¿¼ö

• Â÷µ¿Çö

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  326 ~ 335

• ¾Ç¼º ¸²ÇÁÁ¾¿¡ ´ëÇÑ °í¿ë·® Ç×¾ÏÈ­Çпä¹ý ¹× ÀÚ°¡ Á¶Ç÷¸ð¼¼Æ÷ ÁöÁö¿ä¹ý

• High-dose Chemotherapy with Hematopoictic Stem Cell Support for Malignant Lymphoma

• ¹Ú¿µ¼®

• ÀÌÁ¤¾Ö/¹Î¿ì¼º/¹Ú¼±¾ç/ÀÌÁ¤½Å/±èȿö/±¹ÈÆ/¿øÁ¾È£/È«´ë½Ä

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  316 ~ 325

• ¼ºÀÎÇü µ¿Á¾°ñ¼öÀ̽ÄÀÇ Ä¡·á¼ºÀû(II): 1992-1995

• Clinical Results of Allogeneic Bone Marrow Transplantation in Adults(II): 1992-1995

• Á¶¼®±¸

• Á¤ÀÍÁÖ/ÃÖÁ¤Çö/À¯ÁøÈ«/±èµ¿¿í/ÇÑÄ¡È­/¹Î¿ì¼º/½Å¿Ï½Ä/¹ÚÁ¾¿ø

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  308 ~ 315

• Àç¹ß¼º ¹× ºÒÀÀ¼º ¼ºÀÎ ±Þ¼º¹éÇ÷º´¿¡ ´ëÇÑ High/Intermediated-dose Cytarabine°ú Idarubicin º´¿ë¿ä¹ý

• Treatment of Relapsed or Refractory Acute Leukemia with High/Intermediate-dose Cytarabine and Inarub...

• ±è¼ºÃ¶

• ¹ÎÀ¯È«/³ëÇöÁø/À̽ÂÅÂ/Á¤º¸¿µ/ÇÑÁö¼÷/°íÀ±¿õ

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  301 ~ 307

• È£½ºÇǽºº´µ¿¿¡ ÀÔ¿øÇÑ ¸»±â ¾ÏȯÀÚÀÇ ÅëÁõÁ¶Àý

• Pain Control in the Termial Cancer Patients at Hospice-ward

• ÇÑÁö¿¬

• ±èÀçÀ¯/°­ÁøÇü/¹®ÇѸ²/È«¿µ¼±/±èÈƱ³/ÀÌ°æ½Ä/±èµ¿Áý/¿¬±â¼ø

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  295 ~ 300

• ½ÅÀå¼¼Æ÷¾Ï ¼¼Æ÷ÁÖ¿¡ ´ëÇÑ ¼¼Æ÷À¯ÀüÇÐÀû ºÐ¼®°ú 3¹ø ¿°»öü ÆäÀÎÆà Probe Àû¿ë

• Application of Chromosome 3 Painting Probe and Cytogenetic Analysis on Renal Cell Carcinoma Cell Lin...

• ³ë°æºó

• Àü¿ëÇõ, ¹Ú¼±È­

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  286 ~ 294

• ¿ø¹ß¼º Æó¾Ï¿¡¼­ Ç÷û CEAÄ¡ÀÇ ÃøÁ¤

• Determination of Serum CEA Level in Primary Lung Cancer

• ÃÖÁøÇõ

• ÀåÁßÇö/À̼ø³²/³²Àº¹Ì/¹Ú±â·É/¹Ú»ç¿µ/ÀÌÈ¿Áø/Á¶¼º¹Î/±è¿µ¼±

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  281 ~ 285

• ¿ø¹ß¼º Æó¾Ï¿¡¼­ ¶û°Ô¸£Çѽº ¼¼Æ÷ ¹× T ¸²ÇÁ±¸ÀÇ Ä§À±¾ç»ó

• Distribution of Langerhans Cells Associated with T Lymphocytes in Primary Lung Cancers

• ½Åµ¿È¯

• ±è±Í½Ä, ±èÇü¿Á, ¹Ú±¤È­

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  272 ~ 280

• À¯¹æ¾ÏÀÇ ¿¹ÈÄÀÎÀڷμ­ÀÇ Cathepsin DÀÇ ÀÇÀÇ

• Significance of Cathepsin D as a Prognostic Factor of Breast Cancer

• À̵¿È­

• ±èµ¿¿ø, Çã°æ¹ß

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  261 ~ 271

• À¯¹æ¾ÏÀÇ Flow Cytometric DNA ºÐ¼®

• Flow Cytometric DNA Analysis of Breast Carcinoma

• ¼­±¤¼±

• ¹èÁø¼±

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  253 ~ 260

• À¯¹æ¾Ï¿¡¼­ Matrix-metalloproteinase-9(mMMP-9)ÀÇ ¹ßÇö

• Expression of Matrix-metalloproteinase-9(MMP-9) in Breast Cancer

• ¶ó¼±¿µ

• ±è¼¼Áß/Á¤Çöö/±èÁÖÇ×/³ëÀç°æ/ÀÌ°æ½Ä/±èº´¼ö

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  247 ~ 252

• ´ãµµ°è ¹× ÃéÀå¾ÏÀÇ ¾Ç¼º ´ãµµÆó»ö¿¡ À־ »õ·Î¿î ¸·ºÎÂø¼º ÆØ⼺ ±Ý¼ÓÁ¦ ´ãµµ¹è¾×°ü(Covered Modified-...

• Clinical Trial of the New Membrance Covered Self-expandable Biliary Metal Stent for the Malignant Bi...

• ½ÉÂù¼·

• Á¶¿µ´ö/ºÀÇü±Ù/±èÁø¿À/Á¶ÁÖ¿µ/±è¿¬¼ö/ÀÌÁؼº/À̹®¼º/Ȳ¼­±Ô

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  236 ~ 246

• Á÷Àå¾Ï ȯÀÚ¿¡¼­ ±ÙÄ¡Àû ¼ö¼úÈÄ º¸Á¶Àû ¹æ»ç¼±¿ä¹ý ¹× 5-Fluorouracil À¯ÁöÈ­Çпä¹ýÀÇ Ä¡·áÈ¿°ú

• The Postoperative Adjuvant Radiation Therapy and 5-fluorouracil Maintenance Chemotherapy for Resecta...

• ÀÓ¿µÇõ

• ¼­Ã¢ÀÎ/Çã´ë¼®/¹æ¿µÁÖ/±è³ë°æ/¹ÚÀç°©/ÀÌ°Ç¿í/ÃÖ±¹Áø/ÇϼºÈ¯

• ´ëÇѾÏÇÐȸÁö   1996³â  28±Ç  2È£  225 ~ 235